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Antiserum to the human cutaneous basement membrane-anchoring fibril complex 
specifically binds to the basement membrane zone of normal human skin as demonstrated 
by indirect immunofluorescence and, in addition, cross-reacts with normal human glomer-
ulus . This antiserum does not prevent binding of pemphigoid antibody to its specific 
antigen; thus the antigen of bullous pemphigoid is unlikely to be a component of the 
cutaneous basement membrane (basal lamina). 
The dermal-epidermal junction is an antigeni-
cally heterogenous region wherein a number of 
autoimmune diseases find expression. These in-
clude bullous pemphigoid, herpes gestationis, der-
matitis herpetiformis, lupus erythematosus, and 
others. Recently , isolation of specific antomic [1] 
and protein [2] components of this region has 
provided an opportunity to investigate the anti-
genic properties of separate components of the 
basement membrane zone (BMZ). In this report, 
we describe certain antigenic properties of the 
human cutaneous basement membrane-anchoring 
fibril (CBM-AF) complex [1] and differentiate the 
antigenic activity of the complex from the antigen 
of bullous pemphigoid. 
METHODS 
Epidermis was separated from dermis, using sheets 
of normal human skin obtained promptly after ampu-
tation or autopsy. 2 N N aSCN was used to effect 
separation [3-5]. Basement membrane-anchoring fibril 
complexes were removed from the dermal surface by 
the controlled application of ultrasonic energy as de-
scribed previously [1,4]. CBM-AF complexes were pre-
cipitated from suspension by sedimentation at 600 g for 
5 min. Pooled aliquots of this material were mixed 
with 1 cc complete Freund's adjuvant and injected 
intramuscularly into goats (1-2 mg total dry weight 
antigen per goat) . Booster immunization was carried 
out at 3 weeks by the same method and route of 
administration . 
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ing fibril 
FITC: fluorescein isothiocynate 
IF : immunofluorescence 
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Indirect immunofluorescence (!F) procedures [6] 
were used to test for the presence of antibasement 
membrane antibodies in sera obtained from these goats 
using cryostat sectioned normal huma n skin and kid-
ney as substrates. Fluorescein isothiocynate (F!TC) 
labeled rabbit antigoat sera (Hyland Division , Trav-
enol Laboratori es, Costa Mesa, Calif.) and FITC-la-
beled rabbit antihuman IgG (Behring Diagnostics, So-
merville, New J ersey) were used to detect binding of 
goat sera and bullous pemphigoid sera , respectively. 
RESULTS 
Figure 1 depicts several fragments of CBM-AF 
complex and morphologically defines the antigen 
used in these experiments. Figure 2A depicts the 
binding of serum from a goat immunized with 
CBM-AF complex to the BMZ of normal human 
skin. An antibody titer of 1:1280 as assayed by 
indirect IF was achieved 3 weeks after the second 
immunization. The goats did not develop skin or 
mucous membrane lesions. Figure 2B demon-
strates goat antisera to the CBM-AF complex 
binding to the BMZ of normal human skin despite 
prior layering of human bullous pemphigoid sera 
over the tissue section. In a parallel experiment 
specific binding of human bullous pemphigoid sera 
to the BMZ of normal human skin was shown to 
occur despite prior layering of goat antisera to the 
CBM-AF complex over the tissue section . Figure 
3A depicts goat antiserum to the CBM-AF com-
plex binding to the glomerular basement mem-
brane region of normal human kidney. The ani-
mals did not develop proteinuria, elevated serum 
creatinine or other evidence of renal impairment. 
Figure 3B demonstrates absence of glomerular 
staining when normal goat serum was used as 
control. 
DISCUSSION 
The results of our studies demonstrate that 
antigens in the human CBM-AF complex are 
capable of eliciting production of heterologous 
antibodies which cross-react with renal human 
glomerulus. Basement membrane of glomerular 
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Frc 1. Cutaneous basement membrane-anchoring 
fibril complex (reduced from x 8,000). 
Frc 2. (A) Staining of basement membrane zone of 
normal skin with goat anti-cutaneous basement mem-
brane-anchoring fibril complex serum (reduced from x 
300). (8) Failure of bullous pemphigoid sera to block 
staining of skin with goat anti-cutaneous basement 
membrane-anchoring fibril complex serum (reduced 
from x 300). 
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FIG 3. (A) Binding of goat an ti -cutaneous basement 
membrane-anchoring fibril complex sera to glomerulus 
(reduced from x 300). (B) Failure of normal goat serum 
to stain glomerulus (reduced from x 300). 
origin is known to contain type IV collagen as 
well as noncollagenous glycoprotein components 
[7] . In general, those basement membranes which 
have been subjected to biochemical a nalysis have 
had strikingly similar compositional features ir-
respective of tissue of origin. The recent demon-
stration of type IV collagen in extract of whole 
fetal skin [8] suggests that cutaneous basement 
membrane is similar to other basement mem-
branes in possessing this molecular component. 
Our demonstration of an antigenic similarity be-
tween cutaneous basement membrane and glo-
merular basement membrane reinforces the view 
that the cutaneous basement membrane (basal 
lamina) is not unlike other basement membranes 
in structure and composition . 
In addition, our studies demonstrate that anti-
sera to the CBM-AF complex does not block bind-
ing of pemphigoid antibody to its specific binding 
site. Conversely, pemphigoid sera does not block 
binding of antisera to the CBM-AF complex to its 
binding site. Thus, the antigen of bullous pemphi-
goid is unlikely to be a component of the CBM-AF 
complex. This finding is in accord with recent 
immunoelectron microscopic studies [9] and a re-
cent immunofluorescent study of isolated epider-
mis [5] which localize the pemphigoid antigen to 
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the lower surface of the cytoplasmic membrane of 
the basal cell layer and/or to the lamina lucida. 
An additional feature which serves to distinguish 
the pemphigoid antigen from the CBM-AF com-
plex is the pattern of staining observed on fluores-
cence microscopy. Antisera to either antigen 
stains the BMZ but pemphigoid sera stains in a 
compact linear pattern whereas anti-sera to the 
CBM-AF complex stains in a thicker but some-
what more diffuse pattern. 
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